Related Experiment Videos
Corneal wound healing modulation using basic fibroblast growth factor after excimer laser photorefractive keratectomy
Cornea
|May 1, 1995
Summary
Topical basic fibroblast growth factor (bFGF) significantly accelerates epithelial healing after excimer laser keratomileusis. This treatment also reduced subepithelial haze, addressing key challenges in refractive surgery.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Biomaterials
Background:
- Photorefractive keratectomy (PRK) using excimer lasers is a key refractive surgery technique.
- Clinical use is limited by subepithelial opacity and refractive outcome regression.
- Basic fibroblast growth factor (bFGF) has shown promise in promoting corneal epithelial healing.
Purpose of the Study:
- To investigate the effect of topical bFGF on corneal epithelial and stromal healing after PRK in a rabbit model.
- To evaluate bFGF's potential to mitigate postoperative subepithelial opacity and refractive regression.
Main Methods:
- Excimer laser keratomileusis was performed on 24 rabbits after deepithelialization.
- Eyes were treated with phosphate-buffered saline (control), bFGF, dexamethasone, or bFGF + dexamethasone.
- Epithelial healing speed was assessed via image analysis; corneal opacity was graded biomicroscopically.
Main Results:
- Topical bFGF significantly accelerated epithelial wound healing within 2-3 days (p < 0.001).
- Combined bFGF and steroid therapy did not affect healing rate.
- Subepithelial haze scores were approximately 50% lower in treatment groups compared to controls during the first two months.
Conclusions:
- Topical bFGF is effective in promoting rapid corneal epithelial healing post-PRK.
- bFGF demonstrates potential in reducing subepithelial haze, a common complication.
- Further research into bFGF as an adjunct therapy for refractive surgery is warranted.